XML 21 R8.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities:    
Net income (loss) $ 8,843 $ (34,381)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Loss on extinguishment of debt, net 351 0
Loss on sale or write down of assets, net 6,316 37,512
Depreciation and amortization 83,233 81,524
Amortization of premium on mortgage notes payable (234) (235)
Amortization of share and unit-based plans 5,519 11,003
Straight-line rent and amortization of above and below market leases (2,650) (2,531)
Provision for doubtful accounts 1,826 1,354
Income tax expense (benefit) 346 (2,949)
Equity in income of unconsolidated joint ventures (12,243) (16,872)
Distributions of income from unconsolidated joint ventures 118 155
Change in fair value of financing arrangement obligation (14,265) 4,382
Changes in assets and liabilities, net of dispositions:    
Tenant and other receivables 16,867 11,699
Other assets 9,284 11,473
Due from affiliates 5,148 (2,512)
Accounts payable and accrued expenses 8,715 13,239
Other accrued liabilities (18,334) (17,893)
Net cash provided by operating activities 98,840 94,968
Cash flows from investing activities:    
Development, redevelopment, expansion and renovation of properties (28,256) (49,242)
Property improvements (8,827) (4,968)
Proceeds from repayment of notes receivable 65,348 202
Deferred leasing costs (8,848) (13,384)
Distributions from unconsolidated joint ventures 41,439 418,333
Contributions to unconsolidated joint ventures (63,093) (40,990)
Proceeds from sale of assets 1,015 1,450
Net cash (used in) provided by investing activities (1,222) 311,401
Cash flows from financing activities:    
Proceeds from mortgages, bank and other notes payable 425,000 120,000
Payments on mortgages, bank and other notes payable (397,358) (387,643)
Deferred financing costs (965) (132)
Payments on finance leases (278)  
Payment of finance deposits (4,820) 0
Redemption of noncontrolling interests (27) (65)
Dividends and distributions (114,396) (113,782)
Net cash used in financing activities (92,844) (381,622)
Net increase in cash, cash equivalents and restricted cash 4,774 24,747
Cash, cash equivalents and restricted cash, beginning of period 149,301 143,105
Cash, cash equivalents and restricted cash, end of period 154,075 167,852
Supplemental cash flow information:    
Cash payments for interest, net of amounts capitalized 50,650 46,418
Non-cash investing and financing transactions:    
Accrued development costs included in accounts payable and accrued expenses and other accrued liabilities $ 42,539 $ 36,286